“ASSESSMENT OF BLOOD MARKERS AFTER RADIONUCLIDE THERAPY FOR OSTEOGENIC METASTASIS OF KIDNEY AND PROSTATE CANCER ” (2022) World Bulletin of Public Health, 12, pp. 66–69. Available at: https://scholarexpress.net/index.php/wbph/article/view/1135 (Accessed: 3 February 2026).